Fortune'S Sparsh Healthcare Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 7.00 Cr
as on 08-07-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 12.90 Cr
as on 08-07-2024
- Revenue -1.56%
(FY 2020)
- Profit -2.62%
(FY 2020)
- Ebitda 7.16%
(FY 2020)
- Net Worth 19.24%
(FY 2020)
- Total Assets 7.87%
(FY 2020)
About Fortune'S Sparsh Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 7.00 Cr.
The company currently has active open charges totaling ₹12.90 Cr.
Amit Wagh, Rucha Wagh, Vikas Kude, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100PN2015PTC154429
- Company No.
154429
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2015
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Fortune'S Sparsh Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Wagh  | Additional Director | 01-Jan-2022 | Current |
| Rucha Wagh | Director | 05-May-2021 | Current |
| Vikas Kude | Director | 20-Mar-2015 | Current |
| Rahul Bade | Director | 20-Mar-2015 | Current |
Financial Performance of Fortune'S Sparsh Healthcare.
Fortune'S Sparsh Healthcare Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 1.56% decrease. The company also saw a slight decrease in profitability, with a 2.62% decrease in profit. The company's net worth Soared by an impressive increase of 19.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fortune'S Sparsh Healthcare?
In 2020, Fortune'S Sparsh Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neurostar Hospital Private LimitedActive 5 years 2 monthsAmit Wagh and Rucha Wagh are mutual person
- Maval Healthcare Private LimitedActive 9 years 10 months
Vikas Kude and Rahul Bade are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 21 Jul 2022 | ₹4.90 Cr | Open |
Corporation Bank Creation Date: 28 Apr 2015 | ₹8.00 Cr | Open |
How Many Employees Work at Fortune'S Sparsh Healthcare?
Fortune'S Sparsh Healthcare has a workforce of 24 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fortune'S Sparsh Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortune'S Sparsh Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
